Browse Category

Earnings Reports News 5 January 2026

AMD stock slips after the bell ahead of Lisa Su’s CES keynote — what investors are watching

AMD stock slips after the bell ahead of Lisa Su’s CES keynote — what investors are watching

New York, Jan 5, 2026, 16:27 ET — After-hours Advanced Micro Devices (AMD.O) fell 1.1% to $221.08 in after-hours trading on Monday, the period after the U.S. market closes. Nvidia slipped 0.4% and Intel was little changed. The move comes hours before CEO Lisa Su takes the stage for AMD’s CES opening keynote, scheduled for 9:30 p.m. ET, the company…
Apple stock slips after Foxconn iPhone read-through; AAPL focus turns to earnings

Apple stock slips after Foxconn iPhone read-through; AAPL focus turns to earnings

New York, January 5, 2026, 16:10 EST — After-hours Apple stock fell about 1.5% on Monday, last trading around $267, as investors parsed a mixed update from top iPhone assembler Foxconn and a fresh volley in the smartphone AI race. Reuters The move matters ahead of Apple’s results for the holiday quarter, when iPhone volumes, pricing and services growth tend…
Tesla stock rebounds after seven-session slide as investors refocus on earnings

Tesla stock rebounds after seven-session slide as investors refocus on earnings

New York, January 5, 2026, 16:08 EST — After-hours Tesla (TSLA.O) shares rose about 3.3% on Monday and were last at $452.37, snapping seven straight sessions of losses. The move came as Wall Street climbed, with the Dow hitting a record and investors looking ahead to Friday’s U.S. nonfarm payrolls report. Reuters For Tesla, the swing matters because the stock…
Lumentum stock slides 8% as optics peers stumble; investors eye February earnings update

Lumentum stock slides 8% as optics peers stumble; investors eye February earnings update

New York, January 5, 2026, 15:24 EST — Regular session Shares of Lumentum Holdings Inc fell about 7.6% on Monday, extending a selloff across parts of the optical networking space even as the broader U.S. equity market held higher. The slide matters because Lumentum has been one of the standout winners tied to the buildout of AI data centers, leaving…
Nextpower (NXT) stock slides as solar shares wobble; $90 level and earnings in focus

Nextpower (NXT) stock slides as solar shares wobble; $90 level and earnings in focus

New York, January 5, 2026, 14:56 EST — Regular session Shares of Nextpower Inc (NXT) fell 3.9% to $89.18 in afternoon trading on Monday, retreating from an opening print of $95.13 and an intraday high of $95.50. The stock last traded $3.60 below Friday’s close of $92.78. The Invesco Solar ETF (TAN) slipped 0.8%, while tracker peer Array Technologies (ARRY)…
Thermo Fisher Scientific stock jumps as Evercore lifts target, with earnings in focus

Thermo Fisher Scientific stock jumps as Evercore lifts target, with earnings in focus

New York, Jan 5, 2026, 14:59 EST — Regular session Thermo Fisher Scientific Inc shares rose about 2.4% in afternoon trading on Monday after Evercore ISI raised its price target to $650 from $610 and kept an “outperform” rating, a call that signals expectations for the stock to beat the broader market. The stock was last up 2.4% at $606.63,…
Verizon stock slips below $40 as Wall Street rallies; dividend and Jan. 30 earnings in focus

Verizon stock slips below $40 as Wall Street rallies; dividend and Jan. 30 earnings in focus

New York, January 5, 2026, 14:39 EST — Regular session Verizon Communications Inc. shares fell about 1.3% to $39.99 in afternoon trading on Monday. The dip stands out because Verizon is widely owned as a defensive, income-oriented stock. In a risk-on session — when investors favor higher-risk assets — money can rotate away from dividend payers. Reuters The stock faces…
Accenture stock rebounds nearly 2% as Redburn nudges target; dividend date and March earnings in focus

Accenture stock rebounds nearly 2% as Redburn nudges target; dividend date and March earnings in focus

New York, Jan 5, 2026, 14:34 EST — Regular session Accenture shares rose nearly 2% on Monday, clawing back some ground after last week’s slide as investors weighed another cautious analyst update and upcoming shareholder-return milestones. The move matters because Accenture is closely watched as a read-through on corporate technology budgets, where investors are still debating how quickly discretionary spending…
JNJ stock slips as talc lawsuits return to the spotlight ahead of earnings

JNJ stock slips as talc lawsuits return to the spotlight ahead of earnings

New York, January 5, 2026, 14:35 ET — Regular session Johnson & Johnson (JNJ) stock fell about 2.2% on Monday as investors trimmed defensive healthcare names. Shares were down $4.49 at $202.86 in afternoon trading after touching a session low of $200.94, with about 4.8 million shares traded. The timing matters because early-year positioning has shifted quickly toward cyclicals, leaving…
Fabrinet stock slides nearly 7% today as contract manufacturers sell off; earnings in focus

Fabrinet stock slides nearly 7% today as contract manufacturers sell off; earnings in focus

New York, Jan 5, 2026, 14:29 EST — Regular session Fabrinet (NYSE:FN) shares fell about 6.7% on Monday, bucking a rise in the broader market. The stock was down $32.06 at $447.36 by 2:29 p.m. EST, after swinging between $490.18 and $440.00. The S&P 500 and Nasdaq were up about 0.7% and 0.8%, respectively. The move matters because Fabrinet sits…
GE Aerospace stock hits fresh high as Wall Street sizes up the next earnings test

GE Aerospace stock hits fresh high as Wall Street sizes up the next earnings test

New York, Jan 5, 2026, 14:02 EST — Regular session GE Aerospace shares rose $6.05, or 1.9%, to $326.80 in afternoon trading on Monday. The stock touched $328.54 earlier after opening at $328.26, and has traded between $320.96 and $328.54 with about 2.7 million shares changing hands. The move keeps GE stock near the top of a powerful run and…
SiTime stock slumps 9% after topping Wall Street targets, bucking chip rally

SiTime stock slumps 9% after topping Wall Street targets, bucking chip rally

New York, Jan 5, 2026, 13:54 EST — Regular session SiTime Corp shares slid about 9% on Monday afternoon, reversing an earlier rise and wiping out a chunk of the timing-chip maker’s start-of-year gains. The Nasdaq-listed stock was down $33.46 at $336.50, after trading as high as $382 and as low as $333.33. The move matters because SiTime has become…
1 161 162 163 164 165 310

Stock Market Today

  • Exxel Pharma Launches $13M IPO to Fund FAAH Inhibitor Trials for Chronic Cough and Pain
    February 3, 2026, 12:31 PM EST. Exxel Pharma plans to raise $13.2 million through a $5-per-share IPO on the NYSE American to advance human trials for its lead FAAH inhibitor drug, EX937. FAAH inhibitors target cannabinoid receptors aiming to treat pain and anxiety but have faced clinical setbacks, including past safety concerns and failed trials by major biopharma firms. Exxel's EX937 is designed to avoid the central nervous system, potentially reducing side effects observed in earlier drugs. Proceeds will fund phase 1 trials for refractory chronic cough in Australia, with plans to expand to other indications like migraine and peripheral neuropathies. Exxel holds multiple FAAH candidates licensed from UC Irvine and is evaluating commercialization strategies without detracting from EX937 development. CEO Soren Mogelsvang leads the Colorado-based firm, which has operated since 2017 with a lean team.
Go toTop